Cargando…

Reconstituted Human Upper Airway Epithelium as 3-D In Vitro Model for Nasal Polyposis

BACKGROUND: Primary human airway epithelial cells cultured in an air-liquid interface (ALI) develop a well-differentiated epithelium. However, neither characterization of mucociliar differentiation overtime nor the inflammatory function of reconstituted nasal polyp (NP) epithelia have been described...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Borja Callejas, Francisco, Martínez-Antón, Asunción, Alobid, Isam, Fuentes, Mireya, Cortijo, Julio, Picado, César, Roca-Ferrer, Jordi, Mullol, Joaquim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063947/ https://www.ncbi.nlm.nih.gov/pubmed/24945146 http://dx.doi.org/10.1371/journal.pone.0100537

Ejemplares similares

133 Corticosteroid Rreatment Reduces Tissue Eosinophilia and the Expression of Matrix Metalloproteinases (MMP-1, MMP-2, MMP-7, MMP-9) and Their Tissue Inhibitor (TIMP-1) in Nasal Polyps
por: de Borja Callejas, Fco, et al.
Publicado: (2012)

132 Characterization of 2 Epithelial Cell Air-Liquid Interface (ALI) Culture Models for Human Healthy Nasal Mucosa and Nasal Polyps
por: de Borja Callejas, Fco, et al.
Publicado: (2012)

Effect of Lipopolysaccharide on Glucocorticoid Receptor Function in Control Nasal Mucosa Fibroblasts and in Fibroblasts from Patients with Chronic Rhinosinusitis with Nasal Polyps and Asthma
por: Fernández-Bertolín, Laura, et al.
Publicado: (2015)

Mometasone and desloratadine additive effect on eosinophil survival and cytokine secretion from epithelial cells
por: Mullol, Joaquim, et al.
Publicado: (2011)

Superior effect of MP-AzeFlu than azelastine or fluticasone propionate alone on reducing inflammatory markers
por: Roca-Ferrer, Jordi, et al.
Publicado: (2018)

Signal Transduction Pathways (MAPKs, NF-κB, and C/EBP) Regulating COX-2 Expression in Nasal Fibroblasts from Asthma Patients with Aspirin Intolerance
por: Garcia-Garcia, Francesc Josep, et al.
Publicado: (2012)

Effect of MP‐AzeFlu compared to monotherapy on COX‐2, PGE(2), and EP2 gene expression in upper airway mucosa
por: Vicens‐Artes, Sonia, et al.
Publicado: (2022)

Superior effect of MP‐AzeFlu compared to monotherapy with fluticasone propionate or azelastine on GILZ, MKP‐1 and TTP anti‐inflammatory gene expression in healthy and inflamed upper airway mucosa
por: Vicens‐Artés, Sònia, et al.
Publicado: (2022)

551 The Impact of Nasal Polyposis on Quality of Life Using the Eq-5d Health Profile
por: Alobid, Isam, et al.
Publicado: (2012)

MP29-02* reduces eosinophil survival induced by epithelial cell secretions from nasal mucosa
por: Roca-Ferrer, Jordi, et al.
Publicado: (2015)

Olfactory Dysfunction in Mental Illness
por: Marin, Concepció, et al.
Publicado: (2023)

Management of Mechanical Nasal Obstruction Isolated or Associated to Upper Airway Inflammatory Diseases in Real Life: Use of both Subjective and Objective Criteria
por: Merma-Linares, Carla, et al.
Publicado: (2023)

MicroRNA in United Airway Diseases
por: Liu, Zheng, et al.
Publicado: (2016)

Overuse of diagnostic tools and medications in acute rhinosinusitis in Spain: a population-based study (the PROSINUS study)
por: Jaume, Francesca, et al.
Publicado: (2018)

Reply
por: Mullol, Joaquim, et al.
Publicado: (2020)

Reference Gene Validation for RT–qPCR in PBMCs from Asthmatic Patients with or without Obesity
por: Bantulà, Marina, et al.
Publicado: (2022)

Olfactory dysfunction during COVID-19 pandemic()
por: Izquierdo-Domínguez, Adriana, et al.
Publicado: (2020)

Pérdida del sentido del olfato durante la pandemia COVID-19
por: Izquierdo-Domínguez, Adriana, et al.
Publicado: (2020)

Consensus on the management of united airways disease with type 2 inflammation: a multidisciplinary Delphi study
por: Blanco-Aparicio, Marina, et al.
Publicado: (2023)

Furthering the understanding of olfaction, prevalence of loss of smell and risk factors: a population-based survey (OLFACAT study)
por: Mullol, Joaquim, et al.
Publicado: (2012)

Subtyping of polyposis nasi: phenotypes, endotypes and comorbidities
por: Koennecke, Michael, et al.
Publicado: (2018)

Prostaglandin E2 receptors in asthma and in chronic rhinosinusitis/nasal polyps with and without aspirin hypersensitivity
por: Machado-Carvalho, Liliana, et al.
Publicado: (2014)

What is the Impact of Positive Airway Pressure in Nasal Polyposis? An Experimental Study
por: Balsalobre, Leonardo, et al.
Publicado: (2019)

Rhinosinusitis with nasal polyposis
por: Sharma, S.C.
Publicado: (2018)

Chronic rhinosinusitis with nasal polyps and allergic rhinitis as different multimorbid treatable traits in asthma
por: Castillo, José Antonio, et al.
Publicado: (2023)

Airway fibroepithelial polyposis
por: Labarca, Gonzalo, et al.
Publicado: (2017)

Nasal polyps, aspirin sensitivity, and late onset asthma are crucial to identify severe asthma. clinicaltrials.gov id : nct01513837
por: Castillo, José A, et al.
Publicado: (2015)

A review of nasal polyposis
por: Newton, Jonathan Ray, et al.
Publicado: (2008)

The Loss of Smell and Taste in the COVID-19 Outbreak: a Tale of Many Countries
por: Mullol, Joaquim, et al.
Publicado: (2020)

Emergence of nasal chondrosarcoma in a dog with nasal polyposis
por: Sumner, Judd A., et al.
Publicado: (2018)

Evaluation of nasal symptoms induced by platelet activating factor, after nasal challenge in both healthy and allergic rhinitis subjects pretreated with rupatadine, levocetirizine or placebo in a cross-over study design
por: Muñoz-Cano, Rosa, et al.
Publicado: (2013)

Nasal polyps in patients with asthma: prevalence, impact, and management challenges
por: Langdon, Cristobal, et al.
Publicado: (2016)

Olfactory Dysfunction in a Mexican Population Outside of COVID-19 Pandemic: Prevalence and Associated Factors (the OLFAMEX Study)
por: Castillo-López, Irma Yolanda, et al.
Publicado: (2020)

Mechanism of action of glucocorticoids in nasal polyposis
por: Fernandes, Atílio Maximino, et al.
Publicado: (2015)

The Effect of Bevacizumab and Propranolol on Nasal Polyposis
por: Olgun, Yuksel, et al.
Publicado: (2022)

Pathogenesis of Nasal Polyposis: Current Trends
por: Goulioumis, Anastasios K., et al.
Publicado: (2022)

Nasal allergen provocation test in nasal polyposis with and without allergy
por: Calus, Lien, et al.
Publicado: (2013)

Differences in Inflammatory Cytokine Profile in Obesity-Associated Asthma: Effects of Weight Loss
por: Bantulà, Marina, et al.
Publicado: (2022)

Convergence of two major pathophysiologic mechanisms in nasal polyposis: immune response to Staphylococcus aureus and airway remodeling
por: Pezato, Rogério, et al.
Publicado: (2013)

Decreased Expression of FOXP3 in Nasal Polyposis
por: Roongrotwattanasiri, Kannika, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_63t85b5u55dp4n3dsjvpdifsdk